|
As
a nation, being fit and healthy has never been more important to
us. We are all aware that for optimum health we should take regular
exercise and eat five portions of fruit and vegetables a day, but
how many of us worry about the state of our eyes until we start
to experience problems?
|
|
|
|
|
|
This
lack of awareness about eye health could help to explain why
many of us suffer from unnecessary visual problems as we grow
older.
|
|
|
|
|
|
|
ICaps®
can help maintain healthy eyes, although food supplementation should
not be used as a substitute for a healthy diet. It may also make
up for nutrients you may not be getting enough of through your daily
diet, especially lutein and zeaxanthin. Low levels of these nutrients
can be associated with poor eye health.1
Lutein and zeaxanthin cannot be produced naturally
by the body so we must include a source of these carotenoids within
our diet. They can be found in dark, leafy greens such as kale, spinach and
broccoli, and in sweetcorn and egg yolk. However it may be difficult, and costly
for those on a budget, to consume the large amounts of these foods needed to
provide the recommended daily amounts of lutein and zeaxanthin. This is where
ICaps® may help, packed full of antioxidants, vitamins, minerals and extra lutein,
ICaps® offers the right nutrients in a convenient once-daily tablet.
|
|
|
|
|
|
Many supplements contain 100% RDA (Recommended Daily Amount) of vitamins and minerals. While this may be sufficient to avoid overall deficiency, these are minimum amounts and studies have suggested that these levels are too low to have much of a positive effect on eye health2. Some of the nutrients in ICaps® are therefore deliberately set above the RDA to provide maximum benefit.
|
|
|
|
|
|
|
ICaps®
is the first choice ocular supplement of UK ophthalmologists,
especially aimed at people aged 40 years and over. It is also frequently
recommended by opticians, pharmacists and nutritionists.
|
|
|
References
1. Moeller SM et al. J Am Coll Nutr 2000; 19(5): 522-75.
2. Age-related eye disease study research group (AREDS report no. 8). Arch Ophthalmol 2001; 119(5): 1417-1436.
|
|
|
|
